Blood Research

Cited by CrossRef (22)

  1. Ramón Diez-Feijóo, Marcio Andrade-Campos, Joan Gibert, Blanca Sánchez-González, Lierni Fernández-Ibarrondo, Concepción Fernández-Rodríguez, Nieves Garcia-Gisbert, Laura Camacho, Marta Lafuente, Ivonne Vázquez, Luis Colomo, Antonio Salar, Beatriz Bellosillo. Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas. Cancers 2024;16:321
    https://doi.org/10.3390/cancers16020321
  2. Jingwen Ma, Yan Teng, Huang Youming, Xiaohua Tao, Yibin Fan. Liquid Biopsies. 2024.
    https://doi.org/10.1007/978-1-0716-3346-5_17
  3. Yuko SHIROUCHI, Yuko MISHIMA, Tomoko TAKAYAMA, Sayuri MINOWA, Yuko ISHIHARA, Mikako TAMBA, Mitsuhito HIRANO, Naoki ONDA, Kengo TAKEUCHI, Dai MARUYAMA. Serum cell-free DNA concentration as a possible prognostic marker in newly diagnosed diffuse large B-cell lymphoma. Biomed. Res. 2022;43:99
    https://doi.org/10.2220/biomedres.43.99
  4. Liyuan Dai, Haizhu Chen, Qiaoyun Tan, Yanrong Wang, Lin Li, Ning Lou, Guangyu Fan, Tongji Xie, Rongrong Luo, Shasha Wang, Yu Zhou, Qiaofeng Zhong, Jiarui Yao, Zhishang Zhang, Le Tang, Yuankai Shi, Xiaohong Han. Identification of novel prognostic autoantibodies in diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high‐throughput antigen microarray. Cancer 2024;130:1257
    https://doi.org/10.1002/cncr.35158
  5. Giulia Regazzo, Francesco Marchesi, Manuela Spagnuolo, Ana Belén Díaz Méndez, Serena Masi, Andrea Mengarelli, Maria Giulia Rizzo. Diffuse large B-cell lymphoma: Time to focus on circulating blood nucleic acids?. Blood Reviews 2021;47:100776
    https://doi.org/10.1016/j.blre.2020.100776
  6. Philippe Decruyenaere, Edoardo Giuili, Kimberly Verniers, Jasper Anckaert, Katrien De Grove, Malaïka Van der Linden, Dries Deeren, Jo Van Dorpe, Fritz Offner, Jo Vandesompele. Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies. Front. Oncol. 2023;13
    https://doi.org/10.3389/fonc.2023.1221471
  7. Mengjing Zhao, Qingjuan Li, Jing Yang, Min Zhang, Xiaolan Liu, Hongwei Zhang, Yunpeng Huang, Jing Li, Jiangping Bao, Jingfang Wang, Jun Du, Tao Guan, Liping Su. Application of circulating tumour DNA in terms of prognosis prediction in Chinese follicular lymphoma patients. Front. Genet. 2023;14
    https://doi.org/10.3389/fgene.2023.1066808
  8. Maroun Bou Zerdan, Joseph Kassab, Ludovic Saba, Elio Haroun, Morgan Bou Zerdan, Sabine Allam, Lewis Nasr, Walid Macaron, Mahinbanu Mammadli, Sarah Abou Moussa, Chakra P. Chaulagain. Liquid biopsies and minimal residual disease in lymphoid malignancies. Front. Oncol. 2023;13
    https://doi.org/10.3389/fonc.2023.1173701
  9. Sharafudeen Dahiru Abubakar, Stella Amarachi Ihim, Mansur Aliyu, Mohammad Saffarioun, Gholamreza Azizi. Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal. 2023.
    https://doi.org/10.1016/B978-0-443-19200-5.00019-1
  10. Priscilla Van den Ackerveken, Alison Lobbens, Dorian Pamart, Aristotelis Kotronoulas, Guillaume Rommelaere, Mark Eccleston, Marielle Herzog. Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphoma. Sci Rep 2023;13
    https://doi.org/10.1038/s41598-023-43520-0
  11. Rafael Colmenares, Noemí Álvarez, Santiago Barrio, Joaquín Martínez-López, Rosa Ayala. The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies. Cancers 2022;14:1310
    https://doi.org/10.3390/cancers14051310
  12. Zahra Haider, Tove Wästerlid, Linn Deleskog Spångberg, Leily Rabbani, Cecilia Jylhä, Birna Thorvaldsdottir, Aron Skaftason, Hero Nikdin Awier, Aleksandra Krstic, Anna Gellerbring, Anna Lyander, Moa Hägglund, Ashwini Jeggari, Georgios Rassidakis, Kristina Sonnevi, Birgitta Sander, Richard Rosenquist, Emma Tham, Karin E. Smedby. Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study. Front. Oncol. 2023;13
    https://doi.org/10.3389/fonc.2023.1176698
  13. Samira Nafar, Kamran Hosseini, Negin Shokrgozar, Amir Yousef Farahmandi, Vahab Alamdari-Palangi, Ali Saber Sichani, Jafar Fallahi. An Investigation into Cell-Free DNA in Different Common Cancers. Mol Biotechnol 2023
    https://doi.org/10.1007/s12033-023-00976-9
  14. Liwei Lv, Yuanbo Liu. Clinical Application of Liquid Biopsy in Non-Hodgkin Lymphoma. Front. Oncol. 2021;11
    https://doi.org/10.3389/fonc.2021.658234
  15. Marijana Nesic, Julie S. Bødker, Simone K. Terp, Karen Dybkær, Luca Liberale. Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples. BioMed Research International 2021;2021:1
    https://doi.org/10.1155/2021/5585148
  16. Miaomiao Li, Ning Ding, Lan Mi, Yunfei Shi, Xinhua Du, Yuting Yi, Ling Yang, Weiping Liu, Jun Zhu. Liquid biopsy in diffuse large B-cell lymphoma: utility in cell origin determination and survival prediction in Chinese patients. Leukemia & Lymphoma 2022;63:608
    https://doi.org/10.1080/10428194.2021.1999441
  17. Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa. Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications. Therapeutic Advances in Hematology 2021;12:204062072110139
    https://doi.org/10.1177/20406207211013987
  18. Xueshi Ye, Wanli Li, Lifei Zhang, Junyao Yu. Clinical Significance of Circulating Cell-Free DNA Detection in Multiple Myeloma: A Meta-Analysis. Front. Oncol. 2022;12
    https://doi.org/10.3389/fonc.2022.852573
  19. Fei Qi, Zheng Cao, Bo Chen, Yue Chai, Jing Lin, Junyi Ye, Yuce Wei, Hao Liu, Han Han-Zhang, Xinru Mao, Xiaoli Feng, Mei Dong. Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring. 2021;5:2505
    https://doi.org/10.1182/bloodadvances.2020001637
  20. Shayu Deshpande, Ruslana G. Tytarenko, Yan Wang, Eileen M. Boyle, Cody Ashby, Carolina D. Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Fenghuang Zhan, Faith E. Davies, Gareth J. Morgan, Frits van Rhee, Brian A. Walker. Monitoring treatment response and disease progression in myeloma with circulating cell‐free DNA. European J of Haematology 2021;106:230
    https://doi.org/10.1111/ejh.13541
  21. A. K. Koviazin, L. V. Filatova, I. S. Zyuzgin, A. S. Artemyeva, M. S. Motalkina, Yu. A. Chudinovskikh, E. V. Dobrovolskaya, S. A. Volchenkov, I. L. Polyatskin, S. A. Shalaev, I. V. Ishmatova, A. A. Zverkova, D. S. Burda, S. S. Elkhova, T. Yu. Semiglazova. Short- and long-term outcomes from the upfront high-dose chemotherapy, followed by autologous hematopoietic stem cell transplantation in diffuse large B-cell lymphoma. Medicinskij sovet 2022:104
    https://doi.org/10.21518/2079-701X-2022-16-9-104-116
  22. Xiping Liang, Renzhi Hu, Qiying Li, Chaoyu Wang, Yao Liu. Prognostic factors for diffuse large B-cell lymphoma: clinical and biological factors in the rituximab era. Experimental Hematology 2023;122:1
    https://doi.org/10.1016/j.exphem.2023.03.003
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd